Innate immune signaling in trophoblast and decidua organoids defines differential antiviral defenses at the maternal-fetal interface

  1. Liheng Yang
  2. Eleanor C Semmes
  3. Cristian Ovies
  4. Christina Megli
  5. Sallie Permar
  6. Jennifer B Gilner
  7. Carolyn B Coyne  Is a corresponding author
  1. Duke University, United States
  2. University of Pittsburgh, United States
  3. Cornell University, United States

Abstract

Infections at the maternal-fetal interface can directly harm the fetus and induce complications that adversely impact pregnancy outcomes. Innate immune signaling by both fetal-derived placental trophoblasts and the maternal decidua must provide antimicrobial defenses at this critical interface without compromising its integrity. Here, we developed matched trophoblast and decidua organoids from human placentas to define the relative contributions of these cells to antiviral defenses at the maternal-fetal interface. We demonstrate that trophoblast and decidua organoids basally secrete distinct immunomodulatory factors, including the constitutive release of the antiviral type III interferon IFN-λ2 from trophoblast organoids, and differentially respond to viral infections through the induction of organoid-specific factors. Lastly, we define the differential susceptibility and innate immune signaling of trophoblast and decidua organoids to human cytomegalovirus (HCMV) and develop a co-culture model of trophoblast and decidua organoids which showed that trophoblast-derived factors protect decidual cells from HCMV infection. Our findings establish matched trophoblast and decidua organoids as ex vivo models to study vertically transmitted infections and highlight differences in innate immune signaling by fetal-derived trophoblasts and the maternal decidua.

Data availability

Sequence data have been deposited into Sequence Read Archives SUB11885513.

The following previously published data sets were used

Article and author information

Author details

  1. Liheng Yang

    Department of Molecular Genetics and Microbiology,, Duke University, Durham, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-6842-086X
  2. Eleanor C Semmes

    Department of Molecular Genetics and Microbiology,, Duke University, Durham, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Cristian Ovies

    Department of Molecular Genetics and Microbiology,, Duke University, Durham, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Christina Megli

    Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh, Pittsburgh, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. Sallie Permar

    Department of Pediatrics, Cornell University, Ithaca, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. Jennifer B Gilner

    Department of Obstetrics and Gynecology, Duke University, Durham, United States
    Competing interests
    The authors declare that no competing interests exist.
  7. Carolyn B Coyne

    Department of Molecular Genetics and Microbiology, Duke University, Durham, United States
    For correspondence
    carolyn.coyne@duke.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-1884-6309

Funding

National Institute of Allergy and Infectious Diseases (NIHAI145828)

  • Carolyn B Coyne

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Jan E Carette, Stanford University School of Medicine, United States

Version history

  1. Preprint posted: March 30, 2021 (view preprint)
  2. Received: April 27, 2022
  3. Accepted: August 16, 2022
  4. Accepted Manuscript published: August 17, 2022 (version 1)
  5. Version of Record published: September 13, 2022 (version 2)

Copyright

© 2022, Yang et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 3,478
    Page views
  • 743
    Downloads
  • 11
    Citations

Article citation count generated by polling the highest count across the following sources: Crossref, PubMed Central, Scopus.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Liheng Yang
  2. Eleanor C Semmes
  3. Cristian Ovies
  4. Christina Megli
  5. Sallie Permar
  6. Jennifer B Gilner
  7. Carolyn B Coyne
(2022)
Innate immune signaling in trophoblast and decidua organoids defines differential antiviral defenses at the maternal-fetal interface
eLife 11:e79794.
https://doi.org/10.7554/eLife.79794

Further reading

    1. Chromosomes and Gene Expression
    2. Microbiology and Infectious Disease
    Abdoulie O Touray, Rishi Rajesh ... Igor Cestari
    Research Article

    African trypanosomes evade host immune clearance by antigenic variation, causing persistent infections in humans and animals. These parasites express a homogeneous surface coat of variant surface glycoproteins (VSGs). They transcribe one out of hundreds of VSG genes at a time from telomeric expression sites (ESs) and periodically change the VSG expressed by transcriptional switching or recombination. The mechanisms underlying the control of VSG switching and its developmental silencing remain elusive. We report that telomeric ES activation and silencing entail an on/off genetic switch controlled by a nuclear phosphoinositide signaling system. This system includes a nuclear phosphatidylinositol 5-phosphatase (PIP5Pase), its substrate PI(3,4,5)P3, and the repressor-activator protein 1 (RAP1). RAP1 binds to ES sequences flanking VSG genes via its DNA binding domains and represses VSG transcription. In contrast, PI(3,4,5)P3 binds to the N-terminus of RAP1 and controls its DNA binding activity. Transient inactivation of PIP5Pase results in the accumulation of nuclear PI(3,4,5)P3, which binds RAP1 and displaces it from ESs, activating transcription of silent ESs and VSG switching. The system is also required for the developmental silencing of VSG genes. The data provides a mechanism controlling reversible telomere silencing essential for the periodic switching in VSG expression and its developmental regulation.

    1. Microbiology and Infectious Disease
    2. Plant Biology
    Christopher Kesten, Valentin Leitner ... Clara Sanchez-Rodriguez
    Research Article

    Purinergic signaling activated by extracellular nucleotides and their derivative nucleosides trigger sophisticated signaling networks. The outcome of these pathways determine the capacity of the organism to survive under challenging conditions. Both extracellular ATP (eATP) and Adenosine (eAdo) act as primary messengers in mammals, essential for immunosuppressive responses. Despite the clear role of eATP as a plant damage-associated molecular pattern, the function of its nucleoside, eAdo, and of the eAdo/eATP balance in plant stress response remain to be fully elucidated. This is particularly relevant in the context of plant-microbe interaction, where the intruder manipulates the extracellular matrix. Here, we identify Ado as a main molecule secreted by the vascular fungus Fusarium oxysporum. We show that eAdo modulates the plant's susceptibility to fungal colonization by altering the eATP-mediated apoplastic pH homeostasis, an essential physiological player during the infection of this pathogen. Our work indicates that plant pathogens actively imbalance the apoplastic eAdo/eATP levels as a virulence mechanism.